The regulatory role of cyclic nucleotide phosphodiesterase(s) and cyclic AMP metabolism in relation to progesterone production by gonadotropins has been studied in isolated rat ovarian cells. Low concentrations of choriogonadotropin (0.4-5 ng/ml) increased steroid production without any detectable increase in cyclic AMP, when experiments were carried out in the absence of phosphodiesterase inhibitors. The concentration of choriogonadotropin (lOng/ml) that stimulated progesterone synthesis maximally resulted in a minimal increase in cyclic AMP accumulation and choriogonadotropin binding. Choriogonadotropin at a concentration of lOng/ml and higher, however, significantly stimulated protein kinase activity and reached a maximum between 250 and lOOOng of hormone/ml. Higher concentrations (50-2500ng/ml) of choriogonadotropin caused an increase in endogenous cyclic AMP, and this increase preceded the increase in steroid synthesis. Analysis of dose-response relationships of gonadotropin-stimulated cyclic AMP accumulation, progesterone production and protein kinase activity revealed a correlation between these responses over a wide concentration range when experiments were performed in the presence of 3-isobutyl-1-methylxanthine. The phosphodiesterase inhibitors papaverine, theophylline and 3-isobutyl-1-methylxanthine each stimulated steroid production in a dose-dependent manner. Incubation of ovarian cells with dibutyryl cyclic AMP or 8-bromo cyclic AMP mimicked the steroidogenic action of gonadotropins and this effect was dependent on both incubation time and nucleotide concentration. Maximum stimulation was obtained with 2mM-dibutyryl cyclic AMP and 8-bromo cyclic AMP, and this increase was close to that produced by a maximally stimulating dose of choriogonadotropin. Other 8-substituted derivatives such as 8-hydroxy cyclic AMP and 8-isopropylthio cyclic AMP, which were less susceptible to phosphodiesterase action, also effectively stimulated steroidogenesis. The uptake and metabolism of cyclic [3H]AMP in ovarian cells was also studied in relation to steroidogenesis. When ovarian cells were incubated for 2h in the presence of increasing concentrations of cyclic [3H]AMP, the radioactivity associated with the cells increased almost linearly up to 2501aM-cyclic [3H]AMP concentration in the incubation medium. The 3H label in the cellular extract was recovered mainly in the forms ATP, ADP, AMP, adenosine and inosine, with cyclic AMP accounting for less than 1 % of the total tissue radioactivity. Incubation of cyclic AMP in vitro with ovarian cells resulted in a rapid breakdown of the nucleotide in the medium. The degradation products in the medium have been identified as AMP, adenosine and inosine. The rapid degradation of cyclic AMP by phosphodiesterase(s) makes it difficult to correlate changes in cyclic AMP concentrations with steroidogenesis. These observations thus provide an explanation for the previously observed lack of cyclic AMP accumulation under conditions in which low doses of choriogonadotropin stimulated steroidogenesis without any detectable changes in cyclic AMP accumulation.
. The available evidence suggests that cyclic AMP may be an intracellular mediator of gonadotropins in ovarian steroidogenesis (Marsh et al., 1966; Dorrington & Kilpatrick, 1967; Hermier et al., 1971; Stansfield et al., 1972; Mills, 1975; Channing & Tsafriri, 1977) . Previous studies from this laboratory have shown that although gonadotropin stimulation of progesterone synthesis in ovarian cells was accompanied by an increase in cyclic AMP formation, low concentrations of lutropin and choriogonadotropin were found to stimulate steroidogenesis in vitro without any significant detectable increase in cyclic AMP concentration . These observations have revealed a discrepancy in the relationship between cyclic AMP accumulation and progesterone production in response to low concentrations of tropic hormone, thereby questioning the intermediary role ofcyclic AMP in steroidogenesis in response to low doses of the hormone. Similarly, in the testicular system it has been demonstrated that there is a discrepancy between the amounts of gonadotropins required to saturate the binding sites and to maximally stimulate cyclic AMP formation and steroidogenesis (Catt & Dufau, 1973; Moyle & Ramachandran, 1973; Rommerts et al., 1973; Mendelson et al., 1975) . A similar dissociation between cyclic AMP accumulation and steroid synthesis in response to low doses of tropic hormone has also been described in isolated adrenal cells (Beale & Sayers, 1972; Hudson & McMartin, 1975) . However, a positive correlation between activation of cyclic AMP-dependent protein kinase and steroidogenesis by gonadotropins has been demonstrated in bovine corpus-luteum slices (Ling & Marsh, 1977) and Leydig cells (Cooke et al., 1976) . By assaying free and occupied cyclic AMP-binding sites of the regulatory subunit of protein kinase in basal and hormone-stimulated Leydig cells Dufau et al. (1977) have demonstrated progressive changes in cyclic AMP production and cyclic AMP-receptor activity during steroidogenesis by low concentrations of gonadotropin.
These observations have led us to investigate the quantitative relationship between cyclic AMP accumulation and progesterone production in response to low doses of gonadotropins and the probable role of cyclic nucleotide phosphodiesterases in these processes. In the present study we have examined (a) dose-and time-dependent accumulation of cyclic AMP, activation of cyclic AMP-dependent protein kinase and progesterone production in response to choriogonadotropin and phosphodiesterase inhibitor by the cells, (b) the ability of various cyclic AMP phosphodiesterase inhibitors to enhance the steroidogenesis and to potentiate gonadotropin action, (c) effectiveness of various 8-substituted cyclic AMP derivatives in stimulating progesterone production in comparison with other cyclic nucleotides, and (d) some characteristics of cyclic AMP metabolism in relation to hormonestimulated steroidogenesis. The findings from the present studies provide evidence to suggest that: (1) low doses of choriogonadotropin stimulate steroidogenesis through changes in cyclic AMP concentrations; and (2) choriogonado-1979 202 tropin (sp. radioactivity 5OCi/,g) was prepared as described by Dufau et al. (1972) . [y-32P]ATP was synthesized by the method of Glynn & Chappell (1964) . Dowex AG 1-X2 (200-400 mesh) was purchased from Bio-Rad Laboratories, Richmond, CA, U.S.A. All other reagents were obtained from regular commercial sources and were of highest purity.
Methods
Preparation of dispersed ovarian cells. Interstitial cells were prepared by collagenase dispersion from the ovaries of 25-day-old rats as described previously (Kawano et al., 1975; . The cells were washed twice and resuspended in Medium 109 containing 1 mg of bovine serum albumin/ml (50mg original weight of tissue per ml). Cells were counted in a haemocytometer and viability was determined by dye exclusion after staining in 0.02% Nigrosin. DNA was determined by the method of Burton (1956) After incubation, the reaction was stopped by placing the sample tubes in a boiling-water bath for 3min, and 0.6 ml of water and lOul (approx. 10000c.p.m.) of [1,2-3.HJprogesterone (to monitor recovery) was added and the samples left in the cold overnight. After 12h, samples were extracted with light petroleum and assayed for progesterone by radioimmunoassay as described previously (Kawano et al., 1975; .
Cyclic AMP measurements. Cells were incubated as described above for progesterone production, with the exception that 3-isobutyl-1-methylxanthine (0.5mM) was also present (unless otherwise noted). After incubation, usually for 2h, the tubes were boiled for 5min, transferred to ice and 0.75ml of 10% trichloroacetic acid (w/v), 0.15ml of 1 M-HCl, 180ul of water and 201l of cyclic [3H]AMP (approx.
2000c.p.m.) were added. The samples were stored in the cold overnight. The precipitated proteins were then removed by centrifugation at 5000g for 10min at 40C. The supernatant fractions were processed and assayed for cyclic AMP as described by Gilman (1970 The supernatant was discarded, and the cells were washed with the same volume of the ice-cold medium. The washing procedure did not last more than 4 to 5min and the efflux of intracellular radioactivity occurring during this prodecure was negligible (2-3 % of the total uptake). The residual extracellular radioactivity that was still associated with the cells after the washing procedure did not exceed 3-5 % of the total uptake. This value was similar to that found when extracellular marker [3H]inulin was used (Boumendel-Podevin & Podevin, 1977 suspension was counted for radioactivity to determine total uptake. The remainder of the suspension was centrifuged to remove the precipitated material. The radioactivity in a portion of the resulting supernatant was also measured to determine soluble radioactivity and the remaining supernatant was analysed to determine the intracellular fate of cyclic AMP.
The supernatant was extracted 5 times with watersaturated diethyl ether (2vol.), freeze-dried and analysed by descending paper chromatography on Whatman 3MM paper (4cmx46cm) with ethanol/ 1 M-ammonium acetate, pH 7.4 (7:3, v/v) as solvent system. The chromatograms were developed for 21 h (Kawano et al., 1975) . Strips 1cm long were eluted with 1.5 ml of water and radioactivity associated with a volume of 0.5ml was measured in 10ml of Herberg's fluid (Rapkin, 1964) . In some cases freezedried material was also analysed by chromatography on Dowex-1 and alumina columns (Saloman et al., 1974; Ortmann & Perkins, 1977) . In all the cases standards were run alongside the unknowns.
Assay of phosphodiesterase. The radioisotope method of Thompson & Appleman (1971) , as modified by Boudreau & Drummond (1975) , was used to determine cyclic AMP phosphodiesterase activity (Azhar & Menon, 1977) . The reaction mixture contained 10mM-Tris/HCl (pH7.5), 1mm-MgCl2, 3.75 mM-2-mercaptoethanol, 1 /uM-cyclic
[3H]AMP (containing 1.2x 105c.p.m.) and 20pl of enzyme extract in a final volume of 0.2ml. After incubation at 30°C for 10min the tubes were frozen in a solid C02/methanol mixture, then boiled for 3 min in a boiling-water bath. The tubes were cooled to room temperature, 50pl of a solution of snake venom (Ophiophagus hanna) (I mg/ml) was added to each tube, and the tubes were incubated at 30°C for 10min. The incubation was terminated by the addition of 1 ml of a slurry of Dowex anion-exchange resin (AG 1-X2, 200-400 mesh) in 3mM-acetic acid (1 part resin, 2 parts acetic acid). After centrifugation, 0.5 ml of clear supernatant was counted for radioactivity after the addition of 10mI of Herberg's fluid (Rapkin, 1964) (Ophiophagus hanna) and 0.1 ml of incubation medium in a final volume of 0.2 ml. The tubes were incubated at 30°C for 1 h, and the incubation was terminated by the addition of 1ml of a slurry of Dowex anion-exchange resin. Other details were as described above.
Protein and DNA measurements. Protein concentration was determined by the method of Lowry et al. (1951) , with bovine serum albumin as standard. DNA was assayed by the procedure of Burton (1956) .
Results
Effect of cyclic nucleotide phosphodiesterase inhibitor on cyclic AMP accumulation, protein kinase activation and progesterone production in response to choriogonadotropin
In the absence of the added 3-isobutyl-1-methylxanthine, choriogonadotropin up to 5 ng/ml did not affect the basal cyclic AMP production, whereas 50 and l00ng of hormone/ml increased cyclic AMP accumulation about 5-and 6-fold respectively (Fig. la) . In contrast, in the presence of phosphodiesterase inhibitor, an increase in cyclic AMP production was detectable with choriogonadotropin concentrations as low as 0.65ng/ml, and increased further with increasing concentrations of choriogonadotropin up to 50ng/ml, reaching a maximum at about l00ng/ml. The effect of different concentrations of choriogonadotropin on protein kinase activity is shown in Fig. l(b) . Choriogonadotropin (1Ong/ml), which maximally stimulated steroidogenesis (Fig. 1c) , also stimulated protein kinase activity significantly, both in the presence and absence of phosphodiesterase inhibitor. However, protein kinase activity continued to increase with increasing concentrations of hormone and reached a maximum between 250 to 10OOng/ml (results not shown).
Unlike cyclic AMP accumulation, progesterone production was detectable with very low concentrations of choriogonadotropin even in the absence of phosphodiesterase inhibitor (Fig. 1c) . Progesterone production showed a significant increase with 0.5ng of choriogonadotropin/ml and increased linearly with increasing concentrations of hormone up to lOng/mI and then reached a plateau. Addition of 3-isobutyl-1-methylxanthine (0.5 mM) in the incubation medium itself stimulated progesterone production. Further addition of inhibitor along with increasing concentrations of gonadotropin shifted the dose-response curve, and maximum steroid production was observed with a choriogonadotropin concentration of 2ng/ml. Surprisingly, 3-isobutyl-lmethylxanthine (0.5 mM) in the presence of higher concentrations of choriogonadotropin, i.e. 10-l00ng/mI, decreased the progesterone response (Fig. 1c) Time-and dose-dependent accumulation ofcyclic AMP and progesterone production in response to choriogonadotropin and cyclic nucleotide phosphodiesterase inhibitors Incubation of ovarian cells for 2min to 2h with 0.4 or 2.5 ng of choriogonadotropin/ml in the absence of 3-isobutyl-1-methylxanthine did not elicit an increase in cyclic AMP accumulation over control values. However, with 250ng to 2.5,ug of choriogonadotropin/ml without added phosphodiesterase inhibitor, ovarian cells showed increased cyclic AMP concentrations even after 2min of incubation and reached a plateau after 45-60 min of incubation. Addition of 3-isobutyl-1-methylxanthine (0.5 mM) potentiated the gonadotropin-stimulated cyclic AMP synthesis. Even with concentrations as low as 0.4ng of choriogonadotropin/ml, small but significant stimulation of cyclic AMP was observed when cells were incubated in the presence of phosphodiesterase inhibitor. Incubation of cells with 50ng/ml, 260 ng/ml or 2.5pg/ml along with 3-isobutyl-1-methylxanthine (0.5 mM) caused an immediate increase in cyclic AMP concentration, which continued to increase with increasing incubation time (Fig. 2) .
With maximally stimulating doses of choriogonadotropin, i.e. 50ng/ml, 250ng/ml or 2.5pg/ml, an increase in progesterone production was evident after 20-30min, whereas with 0.4ng/ml a significant increase in progesterone was not observed until after 90min. Addition of 3-isobutyl-1-methylxanthine (0.5mM) itself stimulated steroidogenesis in a timedependent manner. Similarly, 3-isobutyl-1-methylxanthine (0.5mM) greatly potentiated the action of low doses of choriogonadotropins (0.4 and 2.5 ng/ml) on steroidogenesis (Fig. 2) . However, with high doses, i.e. 50ng/mI, 250ng/ml or 2.5,ug/ml of hormone, addition of 3-isobutyl-1-methylxanthine (0.5mM) inhibited the maximum response at all time points compared with that observed in the presence of hormone alone (Fig. 2) . The inhibitory action of 3-isobutyl-1-methylxanthine was dependent on the concentrations of both inhibitor and hormone. With a low concentration of 3-isobutyl-1-methylxanthine (0.5mM) no inhibition in progesterone production was observed, whereas concentrations of 0.25-1 mM inhibited the response elicited by higher doses (50ng/ml, 250ng/ml or 2.5ug/ml) of hormone (results not shown). In the absence of either hormone or 3-isobutyl-1-methylxanthine no increase in progesterone production was detectable even after 2h of incubation. Peytreman et al., 1973) were tested for their effects on progesterone accumulation in ovarian cells. Papaverine was active at the lower concentrations, whereas 3-isobutyl-1-methylxanthine was almost equally effective at higher concentrations (Table 1) . Theophylline and caffeine also stimulated steroidogenesis at higher concentrations. All these drugs also inhibited both soluble and particulateassociated cyclic AMP phosphodiesterases in a dose-related manner. For the soluble enzyme, 3-isobutyl-1-methylxanthine was most effective, followed by papaverine, and then theophylline (Table 2 ). In contrast, papaverine was most effective against the particulate-associated phosphodiesterase, followed by 3-isobutyl-1-methylxanthine, and then theophylline. Although the relative magnitudes of the effects on phosphodiesterase and steroid production varied, all the compounds resembled each other in producing both effects in ovarian cells (Tables 1 and 2 ).
Effect of 8-substituted derivatives of cyclic AMP and other cyclic nucleotides on progesterone production by rat ovarian cells
The addition of dibutyryl cyclic AMP or 8-bromo cyclic AMP to the incubation medium resulted in an increase in progesterone production in a time-and dose-dependent manner. Maximum stimulation was obtained with 1-2mM concentrations of cyclic nucleotides at 2h of incubation. This increase was close to that produced by a maximally stimulatory dose of choriogonadotropin (1Ong/ml). Further. when a maximum stimulatory dose (2mM) of either dibutyryl cyclic AMP or 8-bromo cyclic AMP was added along with a maximum effective dose of choriogonadotropin (lOng/ml), no additive effect was observed, suggesting both agents act through a similar mechanism (results not shown). In contrast, addition of exogenous cyclic AMP in a concentration range of 10pUM to 1 mM did not affect steroidogenesis, whereas concentrations of 2mm or higher slightly enhanced progesterone production. Addition of 3-isobutyl-1 -methylxanthine (0.25 mM) potentiated the action of cyclic nucleotides when lower concentrations (50,UM or less) were tested. However, as in the case of choriogonadotropin, higher concentrations of inhibitor decreased the progesterone production stimulated by the maximum stimulatory dose of cyclic nucleotides (results not shown).
Effects of some other 8-substituted derivatives of cyclic AMP on steroid production are shown in Table 3 . When lower concentrations (0.25rmM) ol these nucleotides were tested, 8-hydroxy cyclic AMP was most effective followed by 8-bromo cyclic AMP and 8-isopropylthio cyclic AMP. At 2.5 mm concentration, both 8-hydroxy cyclic AMP and 8-bromc cyclic AMP were equally effective, followed by 8-methylthio cyclic AMP and 8-isopropylthio cyclic AMP. Methylamino cyclic AMP and 8-amino cyclic AMP were least effective. Other cyclic nucleotides, such as 8-bromo cyclic GMP, cyclic XMP, 1979 cyclic IMP, cyclic dAMP, cyclic dTMP, cyclic GMP, cyclic CMP, and 5'-AMP up to 5 mm concentrations were without any effect. Fig. 3 show concentrationdependent uptake of cyclic [3H]AMP by ovarian cells. As evident from these results, significant amounts of radioactivity were associated with acid-precipitable fraction, suggesting the possibility that considerable degradation of cyclic [3H]AMP had occurred either intracellularly or extracellularly. We then examined the nature of the radioactivity present in the medium and cells after incubation for 120min with 0.1 mM-cyclic [3H]AMP. Again, extensive degradation of cyclic [3H ]AMP was observed in the medium, and the major radioactive component co-migrated with adenosine, adenine and inosine, and to a lesser extent with 5'-AMP. In contrast, the radioactivity from the cellular extract was recovered mainly in the form of ATP, ADP, AMP and adenosine, whereas less than 1 % of the total radioactivity was recovered as cyclic AMP (Table 4 ). To determine whether or not the degradation of cyclic AMP to 5'-AMP and adenosine occurred extracellularly, unlabelled 5'-AMP, adenosine and adenine were added to the incubation medium at a concentration of 1 mm, along with 0.1 mM-cyclic [3H]AMP. Unlabelled adenosine effectively inhibited the uptake Table 2 . Effect ofdifferentphosphodiesterase inhibitors on soluble andparticulate-associated cyclic nucleotide phosphodiesterase activitiesfrom rat ovarian interstitial cells Ovarian cells (5 x 107) were homogenized in sucrose buffer (0.25 M-sucrose in 5 mM-Tris/HCI, pH 7.5) and the homogenate was centrifuged at 400g for 10min. The resulting supernatant was further centrifuged at 105 OOOg for 90min and the supernatant was saved. The sedimented material was rinsed twice with sucrose buffer and finally resuspended in a volume equivalent to the original homogenate. Both these fractions were then tested for phosphodiesterase activity in the presence of different concentrations (0.1-S00uM) of inhibitors. Other details were the same as described in the Table 3 . Effect of8-substituted derivatives ofcyclic AMP on progesterone production in rat ovarian cells Incubation conditions were the same as described in the legend to Fig. 1, except that acid-soluble radioactivity; *, acid-insoluble radioactivity.
(0.1 mM) or 3-isobutyl-1-methylxanthine (0.5 mM) inhibited cyclic [3H]AMP uptake (approx. 70%) with a parallel increase in radioactivity associated with cyclic AMP in the medium.
These results demonstrate that the majority of cyclic AMP is first hydrolysed by membraneassociated phosphodiesterase to 5'-AMP and then to adenosine by 5'-nucleotidase and the resulting nucleoside is taken up by the cells. Further, whatever intact cyclic AMP is taken up by the cells is also hydrolysed instantaneously. To preclude the possibility that cyclic degradation in the medium resulted from metabolism by enzymes leaking from cells, the cells were preincubated in the absence of cyclic AMP and then washed and transferred to another tube for incubation with cyclic AMP. In another set of experiments the ovarian cells were incubated in the absence of cyclic AMP, the cells were removed and the incubation medium was tested for its ability to metabolize cyclic [3H]AMP. Under these conditions no degradation of cyclic [3H]AMP was observed.
Discussion
Previous studies from this laboratory have shown that at physiological concentrations of gonado- tropin, the stimulation of progesterone production could not be correlated well with the accompanying changes in cyclic AMP concentrations in ovarian cells . The present study is an extension of these previous observations, to evaluate the role of cyclic AMP. We have utilized kinetic studies on cyclic AMP formation and steroidogenesis in response to phosphodiesterase inhibitors and gonadotropin, as well as following the qualitative and quantitative changes in cyclic AMP uptake and degradation and the function of cyclic nucleotide phosphodiesterase in these processes.
The kinetic studies of progesterone production, protein kinase activation and cyclic AMP accumulation in response to choriogonadotropin revealed many marked differences. When the experiments were performed in the absence of phosphodiesterase inhibitor, steroid production was partially dissociated from cyclic AMP accumulation. These observations are in agreement with previous studies reported for Leydig cells, where testosterone production was shown to be stimulated by doses of choriogonadotropin that did not result in detectable increases in cyclic AMP (Catt & Dufau, 1973; Moyle & Ramachandran, 1973; Rommerts et al., 1973; Mendelson et al., 1975; Cooke et al., 1976) . However, in the present study a correlation was observed between progesterone production and increase in protein kinase activity ratio, although the latter required higher concentrations for maximum stimulation. Similarly, Cooke et al. (1976) , by following protein kinase activity, and Dufau et al. (1977) , by assaying occupied and unoccupied cyclic AMP-binding sites in relation to gonadotropinstimulated testosterone production in Leydig cells, have also made similar observations. Ling & Marsh (1977) , with bovine corpus-luteum slices, have reported that lutropin (1Ong/ml), which stimulated progesterone production maximally, also resulted in small but significant stimulation of protein kinase activity. Since activation of protein kinase presumably reflects changes in cyclic AMP concentrations, the failure in the present study to detect changes in cyclic AMP in response to low doses of hormone reflects the possibility that the small increase in cyclic AMP is too difficult to detect by the current methodology or that cyclic AMP is rapidly hydrolysed by very active cyclic nucleotide phosphodiesterase(s). The latter possibility seems to be most likely and further strengthened by the observation that when experiments were performed in the presence of 3-isobutyl-1-methylxanthine a better correlation between cyclic AMP, protein kinase and progesterone responses was observed. As evident from Figs. 1 (Muneyama et al., 1971; Miller et al., 1973 Miller et al., , 1975 Khwaja et al., 1975) , showed considerable steroidogenic activity even at lower concentrations. Our results also indicate that no cyclic [3H]AMP was detected in ovarian cells after incubation with labelled nucleotides for 2h. Since extracellular cyclic nucleotide phosphodiesterase activity was detected in the ovarian cells, some of the extracellular cyclic AMP was converted into 5'-AMP, adenosine and inosine before entry into the cells. This conclusion is further strengthened by the observation that AMP, adenosine and inosine elicited inhibition of 3H uptake from the medium, whereas phosphodiesterase inhibitors papaverine and 3-isobutyl-1-methylxanthine decreased the amount of metabolic products of cyclic
[3H]AMP in the incubation medium. The extracellular metabolism of cyclic AMP described in the present paper may explain our observation that cyclic AMP added in vitro to incubation medium had a very limited effect on steroidogenesis in the ovarian cells. Further, the rapid breakdown of cyclic AMP externally and within the ovarian cells may explain the observation that no increment in cyclic AMP was detected when the cells were stimulated with low or physiological concentrations of gonadotropin.
The inhibitory effect ofhigher doses of 3-isobutyl-1-methylxanthine on steroidogenesis, especially at higher concentrations of choriogonadotropin or cyclic nucleotides, could be due to secondary effects in addition to its well known action on cyclic AMP phosphodiesterases (Appleman et al., 1973) . Methylxanthines have -been shown to inhibit steroidogenesis in the adrenal (Halkerston et al., 1966; Kitabchi et al., 1971 ) and testicular systems (Mendelson et al., 1975; Cooke et al., 1976; Williams et al., 1976) . Several possibilities may be considered for this inhibitory effect. Since in rat ovarian cells progesterone synthesis is dependent on macromolecular synthesis (Kawano et al., 1975) it is possible that methylxanthines inhibit progesterone synthesis by inhibiting protein synthesis, especially when cyclic nucleotide phosphodiesterase inhibitors have been shown to inhibit protein synthesis in many systems (Halkerston et al., 1966; Leier & Jungmann, 1971; Stellwagen, 1974) . The possibility that the high concentration of cyclic AMP generated in the presence of 3-isobutyl-1-methylxanthine could lead to the desensitization of cellular responses should also be considered. In addition the inhibition of uptake of precursors (Faust et al., 1977) required for steroidogenesis by methylxanthines cannot be ruled out at the present time.
The experiments described in the present paper provide further evidence in favour of the intermediary role of cyclic AMP in steroidogenesis in response to low doses of hormone. We have presented evidence for the rapid degradation of cyclic AMP and the appearance of degradation products such as ATP, ADP, 5'-AMP and adenosine in the cellular extracts and incubation medium. These observations as well as those on cyclic [3H]AMP-uptake studies, the kinetics of cyclic AMP formation in response to choriogonadotropin and the possible intracellular compartmentation ofcyclic AMP reported previously point out the complicating problems associated with the demonstration of the intermnediary role of cyclic AMP in steroidogenesis in the ovary.
